- In December 2020, Natco Pharma had announced the launch of an antithrombotic drugs medication named Rivaroxaban (RPIGAT). Rivaroxaban is an antithrombotic drugs drug that treats and prevents blood clots. In India, Bayer markets the drug as Xarelto.
- Home
- Our Solution
-
Market Insights
- Market Insights
- News
- Press Release
- Infographics
- Articles
- White Paper
- Case Studies
- Business Case Studies
- Newsletter
-
Our Company
- Our Company
- About Us
- Company News Room
- Investor Relations
- Careers
- Contact